KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Tax Provisions (2017 - 2025)

Twist Bioscience (TWST) has disclosed Tax Provisions for 6 consecutive years, with -$152000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Tax Provisions fell 150.17% to -$152000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $1.2 million, a 111.54% increase, with the full-year FY2025 number at $700000.0, up 16.67% from a year prior.
  • Tax Provisions was -$152000.0 for Q3 2023 at Twist Bioscience, down from $600000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $676000.0 in Q1 2023 to a low of -$10.4 million in Q4 2021.
  • A 5-year average of -$550473.7 and a median of $61000.0 in 2020 define the central range for Tax Provisions.
  • Peak YoY movement for Tax Provisions: crashed 22719.57% in 2021, then soared 553.69% in 2023.
  • Twist Bioscience's Tax Provisions stood at $37000.0 in 2019, then increased by 24.32% to $46000.0 in 2020, then plummeted by 22719.57% to -$10.4 million in 2021, then skyrocketed by 100.73% to $76000.0 in 2022, then tumbled by 300.0% to -$152000.0 in 2023.
  • Per Business Quant, the three most recent readings for TWST's Tax Provisions are -$152000.0 (Q3 2023), $600000.0 (Q2 2023), and $676000.0 (Q1 2023).